Product

Urbesartan hydrochlorothiazide dispersible tablets

English name: Irbesartan and Hydrochlorothiazide Dispersible Tablets

Chinese pinyin: Ebeishatan Qinglvsaiqin Fensanpian

【Approval number】SFDA approval number H20090098

【Specification】Each tablet contains 150mg urbesartan and 12.5mg hydrochlorothiazide.

【Packaging】Aluminum plastic bubble wrap; 7 pieces/box, 10 pieces/box, 14 pieces/box, 21 pieces/box

【Indications】Used to treat essential hypertension. The fixed-dose combination was used to treat patients who could not effectively control their blood pressure with single irbesartan or hydrochlorothiazide.

【Usage and dosage】1 tablet per day. It is used on an empty stomach or at mealtimes to treat patients whose blood pressure cannot be effectively controlled by ebesartan alone or hydrochlorothiazide. It is recommended that patients be adjusted for a single ingredient (i.e., irbesartan or hydrochlorothiazide). For single use of hydrochlorothiazide or hydrochlorothiazide, 150mg cannot effectively control blood pressure. It is not recommended to use a dose of more than 300mg/ hydrochlorothiazide once a day. If necessary, this product may be used in combination with other blood pressure lowering drugs (see [drug interaction]).

【Storage】Keep in a cool, dark place (avoid light and no more than 20℃)

【Back】